Sage Therapeutics, Inc (SAGE) Forvard P/E multiplikatori

Sage Therapeutics Inc. (SAGE) kompaniyasining rasmiy ramzlari

Sage Therapeutics, Inc. (SAGE) noyronlar va markaziy nerv tizimi (CNS) buzilishlarini davolashda yetakchilik qilmoqda va noyob Zurzuvae dori vositasini ishlab chiqdi. GURU.Markets terminali kompaniyaning kutilayotgan P/E koeffitsiyenti grafigini taqdim etadi, bunda 0.00 ko'rsatkichning yangi qiymatiga aylanadi. O'sish potentsiali robotlashtirilgan molekulalarni kashf qilish va optimallashtirilgan xomashyo logistikasi bilan qo'llab-quvvatlanadi, bu esa yangi neyropreparatlar ishlab chiqish jarayonida operatsion uzilishlarni minimallashtiradi.

SAGE - Sage Therapeutics Inc. Prognoz qilingan narx-foyda nisbati 04.07.2022 - 16.08.2025 oraligʻida

Sage Therapeutics, Inc. (SAGE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Fundamental baholash:sagerx.com
Sage Therapeutics Inc tovar namunasi

Prognoz qilinayotgan P/E koeffitsiyenti biznesning bozor qiymatini uning kutilayotgan yillik daromadlariga nisbatan aks ettiradi va bu kelajakdagi pul oqimlari uchun to'langan premiumni baholash imkonini beradi. Sage Therapeutics, Inc. (SAGE) kompaniyasining prognoz qilinayotgan narx-daromad nisbatini tahlil qilish orqali investor fundamental baholash tendentsiyasini aniqlashi mumkin, bu esa Sage Therapeutics, Inc. (SAGE) uchun noelastik talab sharoitida kuchli narx belgilash imkoniyati va og'ir tug'ruqdan keyingi depressiyani davolash uchun aniq tibbiyot vositalarining noyobligi bilan asoslanadi.

Sage Therapeutics, Inc. (SAGE) raqobatchilari

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|ATHA: Prognoz qilingan narxning foydaga nisbati|ADXN (Addex Therapeutics, Ltd.) - Narxning kelajakdagi foydaga nisbati|Alzamend Neuro Inc. (ALZN) - Kelajakdagi narxning foydaga nisbati|Cyclerion - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati protagenic.com|Pasithea Therapeutics - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati CRGT (Cortigent, Inc.)|Avenue Therapeutics - Narxning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Brainstorm Cell BCLI|Forvard P/E multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forvard P/E multiplikatori|eliemtx.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Intra-Cellular Therapies (ITCI) - Kelajakdagi narxning foydaga nisbati|LBPH (Longboard) - Kelajakdagi narxning foydaga nisbati|MRNS (marinuspharma.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati NKGen Biotech NKGN|Kelajakdagi narxning foydaga nisbati NeuroBo Pharma (NRBO)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)